Novartis' trading volume on February 18th was $393 million, ranking 317th among U.S. stocks on that day.

2026-02-19 06:37:20

On February 18, 2026, Novartis (NVS) had a trading volume of $393 million, ranking 317th among U.S. stocks for the day, a decrease of 5.81% from the previous day. The trading volume was 2.3707 million shares.

Novartis (NVS) declined 0.48% on February 18, 2026, closing at $165.38. The stock has increased 3.32% over the past five trading days, 11.23% for the entire month of February, 19.95% since the beginning of the year, and 55.13% over the past 52 weeks.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to listings less than 1 month or fewer than 5 trading days).

Novartis (NVS)	Trading Volume / USD	Change from Previous Day	Volume
February 18, 2026	$393 million	-5.81%	2.3707 million
February 17, 2026	$417 million	36.43%	2.5088 million
February 13, 2026	$306 million	-18.92%	1.877 million
February 12, 2026	$377 million	-13.08%	2.3376 million
February 11, 2026	$434 million	-38.90%	2.7205 million

Novartis AG was incorporated on February 29, 1996, under Swiss law as a joint-stock company. The company is an innovative pharmaceutical firm engaged in research, development, manufacturing, distribution, marketing, and sales of a wide range of medical products. It focuses on core therapeutic areas including cardiovascular, renal and metabolic diseases, immunology, neuroscience, and oncology.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes